Saw this across a few financial websites today.
A Prophylaxis option is seeking approval having just completed its phase 3 trial.
From the looks of it, it uses a pair of antibodies from convalescent patients.
The PROVENT version looks successful at stopping symptoms. There was an earlier version called Storm Chaser that failed earlier this summer.
Just thought I'd share this, as it might be an option for those who might not want to be vaccinated.
The link below is from their website, but you can also find info via Marketwatch etc.
A Prophylaxis option is seeking approval having just completed its phase 3 trial.
From the looks of it, it uses a pair of antibodies from convalescent patients.
The PROVENT version looks successful at stopping symptoms. There was an earlier version called Storm Chaser that failed earlier this summer.
Just thought I'd share this, as it might be an option for those who might not want to be vaccinated.
The link below is from their website, but you can also find info via Marketwatch etc.

Comment